BCL7B
B-cell CLL/lymphoma 7 protein family member B
Also known as: BCL7B_HUMAN, SMARCJ2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BQE9
- Gene
- BCL7B
- Ensembl
- ENSG00000106635
- Chromosome
- 7
- Canonical length
- 202 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a member of the BCL7 family including BCL7A, BCL7B and BCL7C proteins. This member is BCL7B, which contains a region that is highly similar to the N-terminal segment of BCL7A or BCL7C proteins. The BCL7A protein is encoded by the gene known to be directly involved in a three-way gene translocation in a Burkitt lymphoma cell line. This gene is located at a chromosomal region commonly deleted in Williams syndrome. This gene is highly conserved from C. elegans to human. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Oct 2010]
Canonical amino-acid sequenceUniProt
202 residues, UniProt reviewed canonical sequence.
>Q9BQE9|BCL7B
1 MSGRSVRAET RSRAKDDIKK VMAAIEKVRK WEKKWVTVGD TSLRIFKWVP VTDSKEKEKS
61 KSNSSAAREP NGFPSDASAN SSLLLEFQDE NSNQSSVSDV YQLKVDSSTN SSPSPQQSES
121 LSPAHTSDFR TDDSQPPTLG QEILEEPSLP SSEVADEPPT LTKEEPVPLE TQVVEEEEDS
181 GAPPLKRFCV DQPTVPQTAS ESLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BCL7B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.67
- Highest tissue expression
- 97 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 97 nTPM
- bone marrow: 85 nTPM
- blood vessel: 64 nTPM
- heart muscle: 60 nTPM
- colon: 59 nTPM
- tongue: 52 nTPM
Single-cell type
- megakaryocytes: 148 nCPM
- syncytiotrophoblasts: 121 nCPM
- esophageal apical cells: 112 nCPM
- cytotrophoblasts: 90 nCPM
- differentiating spermatogonia: 75 nCPM
- esophageal suprabasal cells: 73 nCPM
Immune cell
- NK-cell: 21 nTPM
- non-classical monocyte: 20 nTPM
- eosinophil: 20 nTPM
- naive B-cell: 18 nTPM
- plasmacytoid DC: 16 nTPM
- intermediate monocyte: 16 nTPM
Brain region
- cerebral cortex: 56 nTPM
- hippocampal formation: 52 nTPM
- amygdala: 48 nTPM
- basal ganglia: 48 nTPM
- hypothalamus: 47 nTPM
- thalamus: 46 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.71
- gnomAD pLI
- 0.19
- gnomAD missense Z
- 1.22
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- cell differentiation
- chromatin remodeling
- negative regulation of cell differentiation
- positive regulation of cell population proliferation
- positive regulation of double-strand break repair
- positive regulation of stem cell population maintenance
- regulation of G0 to G1 transition
- regulation of G1/S transition of mitotic cell cycle
- regulation of mitotic metaphase/anaphase transition
- regulation of nucleotide-excision repair
- regulation of transcription by RNA polymerase II
- Wnt signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BCL7B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BCL7B as an antibody target. Whether an autoantibody or antibody against BCL7B could matter depends on whether native BCL7B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BCL7B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BCL7B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...